Standard SPAC IPO — no operating business to evaluate. Monitor for business combination announcement within 24-month window. The forward purchase agreement with TCG Crossover Fund III provides $20M backstop for the initial business combination, which may reduce dilution risk for public shareholders.
Price Chart
Executive Summary
TCGX Acquisition Corp. II (TCXB) filed an 8-K reporting the execution of an underwriting agreement for its IPO of 10,000,000 Class A ordinary shares at $10.00 per share, with a concurrent private placement of 450,000 Class A shares to the sponsor. The filing also includes the adoption of amended and restated memorandum and articles of association, entry into a registration rights agreement, and the appointment of officers/directors. This is a standard blank-check company IPO filing — the company has no operations and will seek a business combination within 24 months.
Key Financial Metrics
Key Facts
- IPO of 10,000,000 Class A ordinary shares at $10.00 per share, underwritten by Guggenheim Securities
- Underwriters purchase price is $9.90 per share; deferred discount of $0.30 per share payable upon business combination
- Sponsor purchased 2,500,000 Class B founder shares for $25,000 (~$0.01/share)
- Sponsor committed to purchase 450,000 private placement shares at $10.00/share concurrently with IPO
- Forward Purchase Agreement with TCG Crossover Fund III, LP for 2,000,000 Class A shares ($20M gross proceeds) to close with initial business combination
- Amended and restated memorandum and articles of association adopted effective October 15, 2026
- Registration rights granted to holders of founder shares, private placement shares, and working capital shares
- Company must complete a business combination within 24 months of IPO or liquidate
- Trust account established with proceeds from IPO and private placement
- Classified board structure with three classes of directors
Financial Impact
IPO gross proceeds of $100,000,000 from 10,000,000 shares at $10.00; net proceeds deposited in trust account; private placement adds $4,500,000; forward purchase adds $20,000,000 at business combination
Risk Factors
- No identified business combination target — risk of liquidation if no deal within 24 months
- Founder shares represent significant potential dilution (2.5M shares at ~$0.01 vs public at $10.00)
- Deferred underwriting discount ($3M) only payable upon business combination — creates incentive for deal completion
- Forward purchase agreement subject to investment committee approval before definitive agreement
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-425355 |
| Document: tcxb-ex1_1.htm | 0001193125-26-425355 |
| Document: tcxb-ex10_3.htm | 0001193125-26-425355 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | SC 13G | $10.27 | awaiting T+20 | — | $10.27 (+0.00%) |
Oct 26, 2026 today | SC 13G | $10.27 | awaiting T+20 | — | $10.27 (+0.00%) |
Oct 23, 2026 3d ago | SC 13G | $10.49 | awaiting T+20 | — | $10.27 (−2.10%) |
Oct 23, 2026 3d ago | SC 13G | $10.49 | awaiting T+20 | — | $10.27 (−2.10%) |
Oct 20, 2026 6d ago | 3 | $10.50 | awaiting T+20 | — | $10.27 (−2.19%) |
Oct 20, 2026 6d ago | 3 | $10.50 | awaiting T+20 | — | $10.27 (−2.19%) |
Oct 19, 2026 7d ago | 8-K | $10.56 | awaiting T+20 | — | $10.27 (−2.75%) |
Oct 16, 2026 10d ago | 424B4 | $10.40 | awaiting T+20 | — | $10.27 (−1.25%) |
Oct 16, 2026 11d ago | EFFECT | $10.86 | awaiting T+20 | — | $10.27 (−5.43%) |
Oct 15, 2026 11d ago | 3 | $10.86 | awaiting T+20 | — | $10.27 (−5.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers